Insider Transactions in Q3 2020 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2020
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,236
-11.37%
|
$105,900
$25.14 P/Share
|
|
Sep 30
2020
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
12,250
+24.75%
|
-
|
|
Sep 30
2020
|
Abhay Joshi COO, President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
7,382
-6.19%
|
$184,550
$25.14 P/Share
|
|
Sep 30
2020
|
Abhay Joshi COO, President of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+12.79%
|
-
|
|
Sep 30
2020
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,446
-9.85%
|
$136,150
$25.14 P/Share
|
|
Sep 30
2020
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,750
+22.17%
|
-
|
|
Sep 30
2020
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
143,269
-20.05%
|
$3,581,725
$25.14 P/Share
|
|
Sep 30
2020
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
301,000
+29.64%
|
-
|
|
Sep 30
2020
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,051
-11.73%
|
$151,275
$25.14 P/Share
|
|
Sep 30
2020
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+25.34%
|
-
|
|
Sep 28
2020
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-5.43%
|
$861,094
$26.18 P/Share
|
|
Jul 23
2020
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
50,913
+41.79%
|
-
|
|
Jul 23
2020
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
264,439
+24.04%
|
-
|